|
Category: cosmetic agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 63.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 258.50 °C. @ 760.00 mm Hg
|
| Vapor Pressure: | 0.009000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 229.00 °F. TCC ( 109.50 °C. ) (est)
|
| logP (o/w): | 3.920 |
| Soluble in: |
| | water, 1000 mg/L @ 25 °C (exp) | | | water, 89.19 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 2460 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE Sapporo Igaku Zasshi. Sapporo Medical Journal. Vol. 3, Pg. 73, 1952.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | cosmetic agents |
| Recommendation for chlorothymol usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for chlorothymol flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
| | antimicrobial agents | |
| | denaturants | |
| | deodorants | |
| | oral care agents | |
Occurrence (nature, food, other): note
Synonyms:
| 4- | chloro-2-isopropyl-5-methyl phenol | | 4- | chloro-2-isopropyl-5-methylphenol | | 6- | chloro-4-isopropyl-1-methyl-3-phenol | | 4- | chloro-5-methyl-2-(1-methyl ethyl) phenol | | 4- | chloro-5-methyl-2-(1-methylethyl)phenol | | 4- | chloro-5-methyl-2-(methylethyl)phenol | | 4- | chloro-5-methyl-2-(propan-2-yl)phenol | | 4- | chloro-5-methyl-2-propan-2-ylphenol | | 4- | chloro-6-isopropyl-3-methyl phenol | | 4- | chloro-6-isopropyl-3-methylphenol | | 4- | chlorothymol | | 6- | chlorothymol | | mono | chlorothymol | | 6- | chorothymol | | 1- | methyl-3-hydroxy-4-isopropyl-6-chlorobenzene | | | phenol, 4-chloro-5-methyl-2-(1-methylethyl)- | | 2-iso | propyl-4-chloro-5-methylphenol | | | thymol, 6-chloro- |
Articles:
| PubMed: | GABAergic pharmacological activity of propofol related compounds as possible enhancers of general anesthetics and interaction with membranes. |
| PubMed: | Lipophilicity of some GABAergic phenols and related compounds determined by HPLC and partition coefficients in different systems. |
| PubMed: | Acaricidal activities of some essential oils and their monoterpenoidal constituents against house dust mite, Dermatophagoides pteronyssinus (Acari: Pyroglyphidae). |
| PubMed: | Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol. |
| PubMed: | Ointment bases for chlorothymol. |
| PubMed: | A convenient laboratory preparation of chlorothymol, N. F. VIII. |
|